Related Experiment Video

Updated: Aug 15, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Treatment of chronic rhinosinusitis with low-dose, long-term macrolide antibiotics: an evolving paradigm

Umur Hatipoglu1, Israel Rubinstein

  • 1Department of Medicine (M/C 719), University of Illinois at Chicago, 840 South Wood Street, Room 913, Chicago, IL 60616-7323, USA.

Current Allergy and Asthma Reports
|October 12, 2005
PubMed

Insights

Macrolide antibiotics, distinct from their antibacterial action, modulate immune responses and promote healing in chronic respiratory conditions like chronic rhinosinusitis. Further research is needed to confirm their therapeutic potential.

Area of Science:

  • Immunology
  • Pharmacology
  • Otolaryngology

Background:

  • Macrolide antibiotics exhibit immunomodulatory effects in chronic respiratory disorders, separate from their antimicrobial activity.
  • These effects include downregulating excessive immune and inflammatory responses and promoting tissue repair.
  • Chronic rhinosinusitis (CRS) is a condition of persistent mucosal inflammation impacting healthcare resources due to treatment challenges.

Purpose of the Study:

  • To review the potential of macrolide antibiotics as biologic response modifiers for chronic rhinosinusitis.
  • To highlight the need for robust clinical trials to establish their efficacy in CRS treatment.

Main Methods:

  • Review of existing basic research and small clinical studies on macrolide antibiotics in chronic respiratory disorders.
  • Identification of the immunomodulatory mechanisms of macrolides.

Main Results:

  • Macrolide antibiotics demonstrate immunomodulatory properties beneficial for chronic respiratory conditions.
  • Evidence suggests potential efficacy in chronic rhinosinusitis, supported by preliminary research.

Conclusions:

  • Macrolide antibiotics show promise in managing chronic rhinosinusitis by modulating immune responses.
  • Long-term, prospective, double-blind, placebo-controlled studies are essential to validate their clinical utility in CRS.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...